Heart Attack
Research from the United States and Denmark in the area of heart attack described
Published in Cardiovascular Device Liability Week, March 11th, 2007
Study 1: Scientists discuss in "Phosphoinositide 3-kinase gamma/delta inhibition limits infarct size after myocardial ischemia/reperfusion injury" new findings in heart attack. According to recent research published in the journal Proceedings of the National Academy of Sciences of the United States of America, "Although phosphoinositide 3-kinases (PI3Ks) play beneficial pro-cell survival roles during tissue ischemia, some isoforms (gamma and delta) paradoxically contribute to the inflammation that damages these same tissues upon reperfusion. We therefore considered...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cardiovascular Device Liability Week
More Articles from Cardiovascular Device Liability Week
- Financials
Biopure Announces 2007 First Quarter Financial Results - Abdominal Aortic Aneurysm
New abdominal aortic aneurysm study findings reported from University Hospital - Abdominal Aortic Aneurysm
Research from Darthmouth-Hitchcock Medical Center in abdominal aortic aneurysm provides new insights - Abdominal Aortic Aneurysm
Research from Kurume University, Department of Surgery yields new data on abdominal aortic aneurysm - Abdominal Aortic Aneurysm
Study findings on abdominal aortic aneurysm are outlined in reports from Medical School - Abdominal Aortic Aneurysm Epidemiology
Study data from University of Houston, Michael E. DeBakey Department of Surgery provide new insights into abdominal aortic aneurysm epidemiology - More from this issue of Cardiovascular Device Liability Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
